Genomic damage as a biomarker of chronic kidney disease status-Reference-Cited by-同舟云学术

Genomic damage as a biomarker of chronic kidney disease status

Published:2014-09-19 Issue:3 Volume:56 Page:301-312
ISSN:0893-6692
Container-title:Environmental and Molecular Mutagenesis
language:en
Short-container-title:Environ. Mol. Mutagen.

Author:

Corredor Zuray¹,Stoyanova Elitsa¹,Rodríguez-Ribera Lara¹,Coll Elisabet²,Silva Irene²,Diaz Juan Manuel²,Ballarin José²,Marcos Ricard¹³,Pastor Susana¹³

Affiliation:

1. Grup de Mutagènesi; Departament de Genètica i de Microbiologia; Edifici C, Universitat Autònoma de Barcelona; 08193 Bellaterra Cerdanyola del Vallès Spain

2. Fundació Puigvert, Nephology Department; 08025 Barcelona Spain

3. CIBER Epidemiología y Salud Pública, ISCIII; Spain

Funder

Generalitat de Catalunya

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Genetics (clinical),Epidemiology

Reference41 articles.

1. Enhancing the sensitivity of the comet assay as a genotoxicity test, by combining it with bacterial repair enzyme FPG;Azqueta;Mutagenesis,2013a

2. A comparative performance test of standard, medium- and high-throughput comet assays;Azqueta;Toxicol In Vitro,2013b

3. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans;Bonassi;Carcinogenesis,2007

4. Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: Results from a pooled cohort study of 22.358 subjects in 11 countries;Bonassi;Carcinogenesis,2008

5. Telomere shortening and haemodialysis;Boxall;Blood Purif,2006

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA damage in circulating leukocytes measured with the comet assay may predict the risk of death;Scientific Reports;2021-08-18

2. Senescence and the Aging Immune System as Major Drivers of Chronic Kidney Disease;Frontiers in Cell and Developmental Biology;2020-10-09

3. Genotoxic biomarkers in patients on hemodialiasis;Ecological genetics;2020-10-09

4. Micronucleus frequency in chronic kidney disease patients: A review;Mutation Research/Reviews in Mutation Research;2020-10

5. Cell-free DNA as a marker for the outcome of end-stage renal disease patients on haemodialysis;Clinical Kidney Journal;2020-08-24